VASSOL HIGHLIGHTS

UIC NeuroVascular Symposium 2008 – Available Online
In a highlight of this year’s conference, Dr. Sepideh Amin-Hanjani presented NOVA’s role in VERiTAS as a part of a look at NIH-sponsored trials on atherosclerotic cerebrovascular disease. VERiTAS is a multi-center trial examining the relationship between vertebrobasilar blood flow and the risk of posterior circulation stroke.
Watch the video>>

NOVA™ Now Available in Europe
CHICAGO—September 29, 2008 —NOVA™, the most advanced technology to quantitatively and non-invasively measure blood flow using magnetic resonance imaging, will now be available to vascular patients in Europe. Developer and producer VasSol, Inc. this month announced their partnership with Italian distributor Tekmed Instruments. more>>

Register now for the 2nd Annual NeuroVascular Symposium at the University of Illinois at Chicago
Registration is open for the Oct. 4, 2008 symposium in Chicago on existing and emerging therapies for patients with cerebrovascular disease. Hear from a renowned group of neurovascular experts in this one-day program for health care professionals. In addition to prominent UIC faculty speakers, special guest C.A.F. Tukken, MD, Ph.D., pioneer of new techniques in intracranial-extracranial bypass, will lecture on non-occlusive laser-assisted bypass surgery.
For more information, please visit the UIC Neurosurgery department.

NIH awards funding to study NOVA’s role in predicting posterior strokes
August 21, 2008 VasSol’s blood flow measurement software, NOVA, for Quantitative Magnetic Resonance Angiography will be part of an NIH multi-center trial on the relationship between vertebrobasilar blood flow and risk of posterior circulation stroke. The results could shed light on which patients will benefit from higher risk surgical intervention and those patients who can be safely managed on drug therapy only. more>>

March 10,2008 Dr Charbel performed the first ELANA bypass at the University of Illinois Medical Center. more>>

GO TO >> News ARCHIVES